Oncept IL-2
Pharmaceutical
Oncept IL-2
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Kocia interleukina-a rekombinowana w wirusie canarypox (vCP1338) ≥10^6,0 EAID*50.*50% dawki zakaźnej ELISA
Strength
Kocia interleukina-a rekombinowana w wirusie canarypox (vCP1338) ≥10^6,0 EAID*50.*50% dawki zakaźnej ELISA
Pack Size
Oncept IL-2
Form
Liofilizat i rozpuszczalnik do sporządzania zawiesiny do wstrzykiwań
Safety Profile
Contraindications
Oncept IL-2
Side Effects
Oncept IL-2
Scan this QR code to access this page quickly on your mobile device.